saw103

Scott A.. Waldman, MD, PhD

Contact Dr. Waldman

132 South 10th Street
Suite 1170
Philadelphia, PA 19107

(215) 955-6086
(215) fax

Most Recent Peer-reviewed Publications

  1. GUCY2C signaling opposes the acute radiation-induced GI syndrome
  2. ST-producing E. Coli oppose carcinogen-induced colorectal tumorigenesis in mice
  3. Peer Review Certifies Quality and Innovation in Clinical Pharmacology & Therapeutics
  4. Bioactivity of oral linaclotide in human colorectum for cancer chemoprevention
  5. Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer
  6. Prime-boost immunization eliminates metastatic colorectal cancer by producing high-Avidity effector CD8+T cells
  7. Clinical Pharmacology & Therapeutics: Past, Present, and Future
  8. Cardiopoietic cell therapy for advanced ischaemic heart failure: Results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial
  9. Managing Innovation to Maximize Value Along the Discovery-Translation-Application Continuum
  10. EXECUTIVE INTERVIEW - Viral gene: Protein-targeting cancer vaccine could boost survival rates
  11. GUCY2C maintains intestinal LGR5+stem cells by opposing ER stress
  12. Multiregion whole-exome sequencing of matched primary and metastatic tumors revealed genomic heterogeneity and suggested polyclonal seeding in colorectal cancer metastasis
  13. Preclinical Evaluation of a Replication-Deficient Recombinant Adenovirus Serotype 5 Vaccine Expressing Guanylate Cyclase C and the PADRE T-helper Epitope
  14. A survey of physician receptivity to molecular diagnostic testing and readiness to act on results for early-stage colon cancer patients
  15. GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity
  16. Guanylyl cyclase C signaling axis and colon cancer prevention
  17. Guanylyl cyclase C hormone axis at the intersection of obesity and colorectal cancer
  18. Targeting guanylate cyclase C in colorectal cancer: Where are we now?
  19. Association of inflammation prior to kidney transplantation with post-transplant diabetes mellitus
  20. GUCY2C ligand replacement to prevent colorectal cancer